Practical Approach to Evaluating Requests to Test New Antimicrobials
Many new antimicrobials have recently come to market to address the rising threat of multidrug-resistant (MDR) bacteria. Clinical and public health laboratories are critical participants in the management of patients with MDR infections and must develop a plan for antimicrobial susceptibility testing (AST) of these new agents, either in-house or at a reference laboratory.
Read More